AI Summary
StalkDMRC remains in a Stage 4 decline with persistent lower highs and lower lows. Price is oversold and has shown a relief bounce but remains below the declining 9 and 21 EMAs. Short-term timing is unfavorable for additional selling; we will defer action and look to trim into relief rallies into the 9/21 EMA resistance zone.